In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma
1998

Calcium Channel Blockers and Chemotherapy in Lymphoma

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): J Shamash, AH Salam, DC Davies, A Williams, S Joel, TA Lister

Primary Institution: ICRF Department of Medical Oncology, St Bartholomew's Hospital

Hypothesis

Can calcium channel blockers enhance the effectiveness of chemotherapy in treating low-grade non-Hodgkin's lymphoma?

Conclusion

Dantrolene and azumolene showed significant cytotoxic effects on lymphoma cells, while nimodipine did not.

Supporting Evidence

  • Dantrolene and azumolene reduced viable cell counts by 70-90%.
  • Nimodipine showed no significant effect on cell viability.
  • The study suggests further evaluation of dantrolene and azumolene for lymphoma treatment.

Takeaway

Some medicines that block calcium can help kill cancer cells in lymphoma, but one of them didn't work at all.

Methodology

The study used in vitro cell cultures of lymphoma cells to assess the effects of dantrolene, azumolene, and nimodipine on cell viability.

Limitations

The study was conducted in vitro, which may not fully represent in vivo conditions.

Participant Demographics

Seven low-grade B-cell lymphomas were studied, including various subtypes.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication